SCHEMBL19431069

SCHEMBL19431069

COc1ccc(CNCC2(C)CCC3(CC2)OCCO3)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.56
ALDH1A1 P00352 4/20 0.51
POLB P06746 1/20 0.44
HTR2A P28223 2/20 0.44
HTR2C P28335 1/20 0.44
TSHR P16473 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
TP53 P04637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
SLC6A4 P31645 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4780301 0.77 ALDH1A1 (0.54) APLNRALDH1A1POLBTSHRMEN1
SCHEMBL18655396 0.75 ALDH1A1 (0.47) APLNRALDH1A1POLBTSHRMEN1
SCHEMBL783785 0.74 APLNR (1.00) APLNRALDH1A1HTR2AHTR2CTSHR
SCHEMBL7768853 0.71 APLNR (0.86) APLNRALDH1A1HTR2AHTR2CTSHR
SCHEMBL12522890 0.70 APLNR (0.83) APLNRALDH1A1HTR2AHTR2CTSHR
SCHEMBL680457 0.70 APLNR (0.76) APLNRHTR2AHTR2CTSHRMEN1
SCHEMBL29485595 0.70 APLNR (0.76) APLNRHTR2AHTR2CTSHRMEN1
SCHEMBL27166666 0.69 APLNR (0.56) APLNRALDH1A1HTR2AHTR2CTSHR
SCHEMBL6099643 0.69 APLNR (0.80) APLNRALDH1A1HTR2AHTR2CTSHR
SCHEMBL18062276 0.69 CHRM2 (0.53) ALDH1A1POLBMEN1KMT2ADPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3281942-A1 B-LACTAMASE INHIBITOR AND APPLICATION THEREOF Xuanzhu Pharma Co., Ltd. (CN) 2018-02-14 EP disclosed
WO-2017167218-A1 ANTIBACTERIAL COMPOSITION AND USE THEREOF 山东轩竹医药科技有限公司 2017-10-05 WO disclosed